Elion Therapeutics

Bright Angel Therapeutics

This biotechnology company develops small molecule inhibitors to treat patients with drug-resistant and life-threatening fungal infections.

Amplyx

This company develops antifungal and antiviral therapies for patients with compromised immune systems, such as cancer and transplant recipients.

F2G

This biopharmaceutical company develops novel antifungal therapies to treat patients with life-threatening rare and resistant fungal infections.

Melinta Therapeutics

This biopharmaceutical company develops and commercialises antibiotics and antifungals to treat drug-resistant infections in hospital and clinic settings.

Asher Biotherapeutics

This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.

Adagio Therapeutics

This biopharmaceutical company develops monoclonal antibody therapies for the prevention and treatment of viral respiratory diseases, primarily serving immunocompromised patients.

Viamet Pharmaceuticals

This company develops small molecule antifungal medicines for patients with chronic and life-threatening infections using a proprietary metalloenzyme inhibitor design platform.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.